These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36315505)

  • 1. Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Langén VL; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Airaksinen KEJ; Lehto M
    PLoS One; 2022; 17(10):e0276612. PubMed ID: 36315505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of income and educational levels on initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Br J Clin Pharmacol; 2023 Jan; 89(1):351-360. PubMed ID: 35986926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation.
    Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Salmela B; Kalatsova K; Kouki E; Haukka J; Putaala J; Linna M; Aro AL; Mustonen P; Hartikainen J; Lehto M
    Eur J Clin Invest; 2024 Jan; 54(1):e14107. PubMed ID: 37823410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rural-Urban differences in Use of Rhythm Control Therapies in Patients with Incident Atrial Fibrillation: A Finnish Nationwide Cohort Study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Itäinen-Strömberg S; Hartikainen J; Aro AL; Airaksinen KEJ; Lehto M
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141456
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
    Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas.
    Guo J; He M; Magnani JW; Brooks MM; Gellad WF; Hernandez I
    Am J Cardiol; 2020 Sep; 130():64-69. PubMed ID: 32680675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Anticoagulant Therapy and Risk of Admission to Long-Term Care in patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Airaksinen KEJ; Halminen O; Linna M; Jaakkola J; Haukka J; Putaala J; Mustonen P; Langén VL; Kinnunen J; Hartikainen J; Lehto M
    J Am Med Dir Assoc; 2023 Oct; 24(10):1484-1489. PubMed ID: 37348842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Linna M; Haukka J; Putaala J; Tiili P; Lehtonen O; Niemi M; Mustonen P; Kinnunen J; Hartikainen J; Airaksinen KEJ; Lehto M
    Pharmacol Res Perspect; 2022 Jun; 10(3):e00961. PubMed ID: 35599338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
    Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
    Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland.
    Vinter N; Halminen O; Lehto M; Airaksinen KEJ; Andersson T; Wändell P; Holzmann M; Rutherford OC; Halvorsen S; Cordsen P; Frost L; Johnsen SP
    Basic Clin Pharmacol Toxicol; 2023 Aug; 133(2):168-178. PubMed ID: 37230945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Gadsbøll K; Staerk L; Fosbøl EL; Sindet-Pedersen C; Gundlund A; Lip GYH; Gislason GH; Olesen JB
    Eur Heart J; 2017 Mar; 38(12):899-906. PubMed ID: 28110293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019.
    Ajabnoor AM; Parisi R; Zghebi SS; Ashcroft DM; Faivre-Finn C; Morris C; Mamas MA; Kontopantelis E
    Cancer; 2024 Apr; 130(8):1316-1329. PubMed ID: 38115738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
    Khurshid S; Weng LC; Hulme OL; Ellinor PT; Lubitz SA
    Am J Cardiol; 2017 Oct; 120(8):1316-1321. PubMed ID: 28823487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Jaakkola J; Airaksinen KEJ; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Hartikainen J; Luojus A; Niemi M; Linna M; Lehto M
    J Am Heart Assoc; 2022 Mar; 11(6):e024119. PubMed ID: 35229612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
    Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
    J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation.
    Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A
    J Am Heart Assoc; 2019 Dec; 8(24):e014287. PubMed ID: 31795822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in preadmission oral anticoagulant use and clinical outcome in atrial fibrillation patients admitted with acute stroke in Denmark.
    Larsen LK; Ovesen C; Frost L; Damgaard D; Christensen H; Johnsen SP
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):112-120. PubMed ID: 31855254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
    Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
    Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.